Building on 25 years of experience in the biopharmaceutical industry, Georg Roth, Ph.D., founded Roth Bioprocess Consulting (RBC) to support the development of complex Biologics.

Until 2019 Dr. Roth was the COO and SVP Technical Operations of Sillajen Biotherapeutics. Previously, he was VP of Technical Operations at Jennerex Biotherapeutics in charge of process development and manufacturing. He also held positions at Dynavax Technologies, Berlex Laboratories and Schering AG (acquired by Bayer AG).

Dr. Roth is a member of several international consulting networks and a senior advisor to Biotech Alliances International a boutique investment bank.

He holds a Ph.D. in Chemical Engineering from Technical University Berlin, Germany.